Literature DB >> 19703820

Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden.

Zohreh Rahimi1, Hadi Mozafari, Amir Hossein Amiri Bigvand, Reza Mohammad Doulabi, Asad Vaisi-Raygani, Dariush Afshari, Nazanin Razazian, Mansour Rezaei.   

Abstract

The present study aimed at investigating the prevalence of factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T in cerebral venous and sinus thrombosis (CVST) patients and their possible association with CVST in Western Iran. A total of 24 CVST patients with the mean age of 37.1 +/- 11.7 years and 100 sex- and age-matched healthy individuals from Kermanshah Province of Iran with ethnic background of Kurd were studied for factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T by PCR-RFLP method using Mnl I, Hind III, and Hinf I restriction enzymes, respectively. Prevalence of factor V Leiden was 16.7% in patients and 2% in control group. A significant association was found between factor V Leiden mutation and CVST with odds ratio (OR) of 9.8 (95% confidence intervals [CI] 1.68-57.2, P = .01). No prothrombin G20210A was found among patients. In patients, MTHFR C677T tended to be higher (58.3%) compared to control (44%), OR of 1.8 (95% CI 0.73-4.5, P = .2). Our study for the first time has determined the prevalence of inherited thrombophilia in a homogenous ethnic group of CVST patients and suggests that factor V Leiden, and not the prothrombin gene mutation is a risk factor for CVST in Western Iran.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19703820     DOI: 10.1177/1076029609335519

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  10 in total

1.  Thrombophilic mutations and susceptibility to preeclampsia in Western Iran.

Authors:  Shohreh Malek-Khosravi; Zohreh Rahimi; Ziba Rahimi; Faranak Jalilvand; Abbas Parsian
Journal:  J Thromb Thrombolysis       Date:  2012-01       Impact factor: 2.300

2.  The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria.

Authors:  Zohreh Rahimi; Vahid Felehgari; Mehrali Rahimi; Hadi Mozafari; Kheirollah Yari; Asad Vaisi-Raygani; Mansour Rezaei; Shohreh Malek-Khosravi; Habibolah Khazaie
Journal:  Mol Biol Rep       Date:  2010-09-19       Impact factor: 2.316

3.  Sickle cell disease and venous thromboembolism.

Authors:  Zohreh Rahimi; Abbas Parsian
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-05-24       Impact factor: 2.576

4.  A case-series study of cerebral venous thrombosis in women using short course oral contraceptive.

Authors:  Payam Khomand; Kambiz Hassanzadeh
Journal:  Iran J Neurol       Date:  2016-04-03

5.  Polymorphisms at activated protein C cleavage sites of factor V: Are they important in the absence of factor V Leiden?

Authors:  Ehsan Kheradmand; Shaghayegh Haghjooy-Javanmard; Leila Dehghani; Mohammad Saadatnia
Journal:  Iran J Neurol       Date:  2017-01-05

6.  Clinical associations, biological risk factors and outcomes of cerebral venous sinus thrombosis.

Authors:  Hafize Nalan Gunes; Burcu Gokce Cokal; Selda Keskin Guler; Tahir Kurtulus Yoldas; Umit Yavuz Malkan; Cemile Sencer Demircan; Mehmet Ilker Yon; Zeynep Yoldas; Gursel Gunes; Ibrahim Celalettin Haznedaroglu
Journal:  J Int Med Res       Date:  2016-11-10       Impact factor: 1.671

7.  Factor V Leiden Mutation Frequency and Geographical Distribution in Turkish Population.

Authors:  Eray Yıldız; Funda Müşerref Türkmen
Journal:  J Transl Int Med       Date:  2020-12-31

8.  Cerebral venous-sinus thrombosis: a case series analysis.

Authors:  Nahid Ashjazadeh; Afshin Borhani Haghighi; Maryam Poursadeghfard; Hoseinjan Azin
Journal:  Iran J Med Sci       Date:  2011-09

Review 9.  Prevalence and Geographical Variation of Prothrombin G20210A Mutation in Patients with Cerebral Vein Thrombosis: A Systematic Review and Meta-Analysis.

Authors:  Joaquín V Gonzalez; Andrés G Barboza; Fernando J Vazquez; Esteban Gándara
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

10.  Factor V Leiden, factor V Cambridge, factor II GA20210, and methylenetetrahydrofolate reductase in cerebral venous and sinus thrombosis: A case-control study.

Authors:  Mohammad Saadatnia; Mansour Salehi; Ahmad Movahedian; Seyed Ziaeddin Samsam Shariat; Mehri Salari; Marzieh Tajmirriahi; Elham Asadimobarakeh; Rasoul Salehi; Gilda Amini; Homa Ebrahimi; Ehsan Kheradmand
Journal:  J Res Med Sci       Date:  2015-06       Impact factor: 1.852

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.